Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07175025 · ClinicalTrials.gov registry record · NA
The New Empowerment After eXposure to Trauma (NEXT) Study
A NA study of PTSD - Post Traumatic Stress Disorder and PTSD (Childbirth-Related), sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 106
- Enrollment target
- 1
- Study location
NCT07175025: Recruiting NA study of PTSD - Post Traumatic Stress Disorder and PTSD (Childbirth-Related), sponsored by Indiana University.
NCT07175025 is a NA study of PTSD - Post Traumatic Stress Disorder and PTSD (Childbirth-Related) that is actively recruiting participants, run by Indiana University. The registered enrollment target is 106 participants, below the 272-participant average among 14 other PTSD - Post Traumatic Stress Disorder trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07175025, a NA study of PTSD - Post Traumatic Stress Disorder and PTSD (Childbirth-Related), is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
- 1
- Study location
Study Summary
The NEXT Study is a randomized controlled pilot examining the feasibility and acceptability of a revised perinatal PTSD protocol. This study will randomize perinatal participants with PTSD to receive NET (n=45); treatment group) and will be compared to perinatal women randomized to usual care (n=45; comparator group). The overall objective of this project is to determine the most feasible and acceptable protocol for a brief virtual perinatal PTSD intervention.
Primary Outcome
The investigators will determine feasibility by enrollment (≥75% of potential participants enroll), treatment adherence (≥80% of treatment group complete 5/6 NET sessions), assessment completion/each time point (≥75% of sample), and study completion (≥75% of sample).
Conditions Studied
Interventions
- BEHAVIORAL Narrative Exposure Therapy (NET)
Study Locations (1)
Indiana
- Indiana University School of Medicine - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2025-09-15 |
| Est. Completion | 2028-07-31 |
| Phase | NA |
What NCT07175025 shows while recruiting
NCT07175025 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 272-participant average among 14 other PTSD - Post Traumatic Stress Disorder trials with a reported enrollment target (61% lower).
The record links to 2 conditions, with PTSD - Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Narrative Exposure Therapy (NET) is the first listed.
NCT07175025 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT07175025 about?
NCT07175025 is a clinical study titled "The New Empowerment After eXposure to Trauma (NEXT) Study". The NEXT Study is a randomized controlled pilot examining the feasibility and acceptability of a revised perinatal PTSD protocol. This study will randomize perinatal participants with PTSD to receive NET (n=45); treatment group) and will be compared to perinatal women randomized to usual care (n=45;...
What is the current status of trial NCT07175025?
This trial is currently recruiting. It is a NA study. The enrollment target is 106 participants. The study started on 2025-09-15. Estimated completion is 2028-07-31.
What conditions does trial NCT07175025 study?
This clinical trial studies the following conditions: PTSD - Post Traumatic Stress Disorder, PTSD (Childbirth-Related).
What interventions are being tested in trial NCT07175025?
The interventions under investigation include: Narrative Exposure Therapy (NET) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07175025?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07175025 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD - Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07175025's enrollment target sits among peer trials
106 7th of 14 higher than 8 of 14 other PTSD - Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD - Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Diet and Microbiome Interactions: Application in Posttraumatic Stress Disorder in Adults Consuming Vegetable Drinks
RECRUITING · NA
-
Transcranial Magnetic Stimulation in Veterans With PTSD
RECRUITING · NA
-
Empowering Perinatal Adolescents Through Writing
RECRUITING · NA
-
Restorative Early Sleep Treatment After the Emergency Department
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI